1,483
Views
0
CrossRef citations to date
0
Altmetric
Cancer Biology

Inflammatory undifferentiated pleomorphic sarcoma of the kidney with obstinate cough and fever as the first symptom: a case report and literature review

, , , , , & show all
Pages 220-225 | Received 20 Dec 2020, Accepted 13 Mar 2021, Published online: 29 Mar 2021

References

  • Agrawal A, Sahni S, Iftikhar A, Talwar A. 2015. Pulmonary manifestations of renal cell carcinoma. Respir Med. 109:1505–1508.
  • Altunkol A, Savas M, Ciftci H, Gulum M, Yagmur I, Bitiren M. 2014. Primary giant cell malignant fibrous histiocytoma-associated with renal calculus. Can Urol Assoc J. 8:E193–E195.
  • Bairwa S, Sangwaiya A, Ansari M, Jindal A, Singla S, Yadav A. 2017. Malignant fibrous histiocytoma arising from renal capsule: an extremely rare entity. Indian J Pathol Microbiol. 60:402–404.
  • Chen S, Huang W, Luo P, et al. 2019. Undifferentiated pleomorphic sarcoma: long-term follow-up from a large institution. Cancer Manag Res. 11:10001–10009.
  • Chen CH, Lee PS, Han WJ, Shen KH. 2003. Primary giant cell malignant fibrous histiocytoma of the kidney with Staghorn calculi. J Postgrad Med. 49:246–248.
  • Delisca GO, Mesko NW, Alamanda VK, et al. 2015. MFH and high-grade undifferentiated pleomorphic sarcoma – what's in a name? J Surg Oncol. 111:173–177.
  • Demizu Y, Jin D, Sulaiman NS, et al. 2017. Particle therapy using protons or carbon ions for unresectable or incompletely resected bone and soft tissue sarcomas of the pelvis. Int J Radiat Oncol Biol Phys. 98:367–374.
  • Ebrahimtabar F, Shafi H, Ranaee M, Darzi MM. 2019. A rare case of primary malignant fibrous histiocytoma: a sarcoma of the kidney. BMC Urol. 191:45.
  • Eroğlu M, Bakirtaş H, Cimentepe E, Unsal A, Ataoğlu O, Balbay MD. 2005. Malignant fibrous histiocytoma arising from the renal capsule. Urol Int. 75:368–370.
  • Estfan B, Walsh D. 2008. The cough from hell: diazepam for intractable cough in a patient with renal cell carcinoma. J Pain Symptom Manage. 36:553–558.
  • Ghosh A, Dwivedi US, Kumar A. 2008. Inflammatory malignant fibrous histiocytoma of kidney: a case report. Pathol Res Pract. 204:857–861.
  • Gronchi A, Ferrari S, Quagliuolo V, et al. 2017. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 18:812–822.
  • Gu J, Zhang S, Wu X, et al. 2015. Malignant fibrous histiocytoma of visceral organs: clinicopathologic features and diagnostic value of ezrin and HMG-CoA reductase. Int J Clin Exp Pathol. 8:2876–2887.
  • Guan X, Gao J, Hu J, et al. 2019. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine. Radiat Oncol. 14:206.
  • Gupta R, Gupta S, Aggarwal D, Singh S. 2008. Primary pleomorphic undifferentiated sarcoma of the kidney: a rare renal tumor. Indian J Pathol Microbiol. 51:573–576.
  • Henderson MT, Hollmig ST. 2012. Malignant fibrous histiocytoma: changing perceptions and management challenges. J Am Acad Dermatol. 67:1335–1341.
  • Hwang SS, Park SY, Park YH. 2010. The CT and F-FDG PET/CT appearance of primary renal malignant fibrous histiocytoma. J Med Imaging Radiat Oncol. 54:365–367.
  • Jo VY, Doyle LA. 2016. Refinements in sarcoma classification in the current 2013 World Health Organization classification of tumors of soft tissue and bone. Surg Oncol Clin N Am. 25:621–643.
  • Karaosmanoğlu AD, Onur MR, Shirkhoda A, Ozmen M, Hahn PF. 2015. Unusual malignant solid neoplasms of the kidney: cross-sectional imaging findings. Korean J Radiol. 16:853–859.
  • Kearney MM, Soule EH, Ivins JC. 1980. Malignant fibrous histiocytoma: a retrospective study of 167 cases. Cancer. 45:167–178.
  • Keung EZ, Tsai J-W, Ali AM, et al. 2018. Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy. Oncoimmunology. 7:e1385689.
  • Kim SJ, Ahn BC, Kim SR, et al. 2002. Primary malignant fibrous histiocytoma of the kidney. Yonsei Med J. 43:399–402.
  • Kwak H-S, Kim C-S, Lee J-M. 2003. MR findings of renal malignant fibrous histiocytoma. Eur Radiol. 13(Suppl 6):L245–L246.
  • Maher SA, Birrell MA, Belvisi MG. 2009. Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy. Am J Respir Crit Care Med. 180:923–928.
  • Miwa S, Nishida H, Tsuchiya H. 2017. Current status of immunotherapy for sarcomas. Immunotherapy. 9:1331–1338.
  • Nathenson MJ, Conley AP, Sausville E. 2018. Immunotherapy: a new (and old) approach to treatment of soft tissue and bone sarcomas. Oncologist. 23:71–83.
  • O'Brien JE, Stout AP. 1964. Malignant fibrous xanthomas. Cancer. 17:1445–1455.
  • Patel VR, Morganstern BA, Kavoussi LR. 2017. Persistent cough as a paraneoplastic presenting symptom in six patients with renal cell carcinoma. Asian J Urol. 4:10–13.
  • Schaefer I-M, Fletcher CDM. 2018. Recent advances in the diagnosis of soft tissue tumors. Pathology. 50:37–48.
  • Shah C, Verma V, Takiar R, et al. 2016. Radiation therapy in the management of soft tissue sarcoma: A clinician's guide to timing, techniques, and targets. Am J Clin Oncol. 39:630–635.
  • Singh SK, Mandal AK, Agarwal MM, Das A. 2006. Primary renal inflammatory malignant fibrous histiocytoma: a diagnostic challenge. Int J Urol. 13:1000–1002.
  • Sullivan S. 2016. Paraneoplastic cough and renal cell carcinoma. Can Respir J. 2016:5938536.
  • Uehara T, Fujiwara T, Takeda K, Kunisada T, Ozaki T, Udono H. 2015. Immunotherapy for bone and soft tissue sarcomas. Biomed Res Int. 2015:820813.
  • Vodanovich DA, Spelman T, May D, Slavin J, Choong PFM. 2019. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases. ANZ J Surg. 89:1045–1050.
  • Vuruskan BA, Ozsen M, Coskun B, Yalcinkaya U. 2019. Evaluation of incidence and histolopathological findings of soft tissue sarcomas in genitourinary tract: Uludag University experience. Int Braz J Urol. 45:68–73.
  • Winchester D, Lehman J, Tello T, et al. 2018. Undifferentiated pleomorphic sarcoma: factors predictive of adverse outcomes. J Am Acad Dermatol. 79:853–859.
  • Zhu Y, Hao D. 2018. Tang X and Sun L: undifferentiated high-grade pleomorphic sarcoma of ethmoid sinus: a case report and literature review. Braz J Otorhinolaryngol. 84:389–392.